Lindsay Blazin, MD
Lindsay Blazin, MD, is a former hematology-oncology fellow at St. Jude Children’s Research Hospital.
Medulloblastoma and microirradiation: Tiny treatments for the most common malignant pediatric brain tumor
| Feb 18, 2019Medulloblastoma may soon be treated by a microirradiator - a machine the size of two refrigerators that beams radiation down to half the width of a credit card.
Learn moreBlazing through new territory to fight a devastating neurodegenerative disease
| Jan 17, 2019Read how researchers have found a path to control coenzyme A and possibly prevent a devastating neurodegenerative disease.
Learn moreGenetic sequencing: How do we put out the fires of genetically driven cancers?
| Nov 8, 2019Too much of a good thing? Read how genetic sequencing offers insights into the causes of some cancers, but the avalance of data creates a new set of issues.
Learn moreOptimizing leukemia treatment through pharmaceutical science
| Jun 19, 2019Effective leukemia treatment is one thing – making sure it’s optimized with minimal implications is another. Read research juggles both to help patients.
Learn moreSeparating fact from fiction using pharmacogenetics
| Oct 8, 2019Improving understanding of drugs and how the body reacts to them - - Read how science is improving understanding of genes and medication.
Learn moreIn times of sorrow, being present to offer comfort and support often matters more than the right words or actions
| Oct 12, 2017Being present after the death of a friend or loved one often matters more to those suffering grief than the right words or actions.
Learn moreSupercharging T cells to fight cancer
| Nov 28, 2017St. Jude researchers are combining therapeutic methods that induce epigenetic reprogramming with immune checkpoint blockade to enhance cancer treatments.
Learn moreHelping childhood cancer survivors thrive
| Sep 18, 2017Discover how St. Jude is helping cancer survivors manage the long-term effects of treatment and set up screening guidelines for those still in treatment.
Learn moreDiscovering new molecular switches to control autoinflammatory disease
| Aug 4, 2017Is Ptpn6, a controlling gene, linked with the master immune switch IL-1 alpha? Can this link be mapped to help pinpoint immune system response? Find out more.
Learn moreApoptosis or necroptosis? The caspase-8 protein decides
| Oct 20, 2017Programmed cell death can affect immune response to diseases such as cancer. Learn how caspase-8 chooses cell death and how that decision can be stopped.
Learn more